|
Sign In to gain access to subscriptions and/or personal tools.
|
Review: When should bariatric surgery be used in the treatment of type 2 diabetes?
Jonathan Pinkney
Department of Medicine, University of Liverpool, jpinkney{at}liverpool.ac.uk
David Kerrigan
Department of Surgery, University Hospital Aintree, Liverpool
Non-randomised observational studies show that bariatric surgery has a highly beneficial impact on diabetes. Bariatric surgery leads to remission of bariatric surgery has a highly beneficial impact on Diabetes. Bariatric surgery leads to remission of diabetes in at least two thirds of patients, and reductions in drug therapy for many others. Those with more recent onset diabetes, fewer treatment requirements, and able to achieve most weight loss are more likely to achieve remission. Therefore, bariatric surgery is an attractive treatment option to consider for selected more severely obese patients with favourable characteristics. Although data on bariatric surgery in subjects with diabetes are provocative, all recent clinical studies have been uncontrolled or otherwise flawed. Moreover, bariatric surgery has yet to be compared either with medical treatment for weight loss, or against standard medical treatment for diabetes in any randomised controlled trial with diabetes-specific end points. There remains a need for long-term randomised controlled trials before bariatric surgery is used more widely as a first-line treatment for obese patients with type 2 diabetes.
Key Words: bariatric surgery obesity diabetes.
References
- Colditz GA, Willett WC, Rotnitzky A., Manson JE Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122: 481-6.[Abstract/Free Full Text]
- Chan JM, Stampfer MJ, Rimm EB, Willett WC, Colditz GA Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-9.[Abstract]
- Tuomilehto J., Lindstrom J., Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1390-2.[Free Full Text]
- Knowler WC, Barrett-Connor E., Fowler SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.[Abstract/Free Full Text]
- Pinkney JH, Kerrigan D. Current status of bariatric surgery in the treatment of type 2 diabetes. Obesity Reviews 2004;5:69-78.[CrossRef][Medline]
[Order article via Infotrieve]
- Sjostrom CD, Lissner L., Wedel H., Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS intervention study. Obesity Res 1999;7:477-85.[Web of Science][Medline]
[Order article via Infotrieve]
- Sjöström CD, Peltonen M., Wedel H., Sjöström L. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000;36:20-5.[Abstract/Free Full Text]
- Long SD, O'Brien K., MacDonald KG et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. Diabetes Care 2003;17:372-5.
- Gu K., Cowie CC, Harris MI Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998;21:1138-45.[Abstract]
- Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM Excess mortality in a population with diabetes and the impact of material deprivation:
- longitudinal, population based study. BMJ 2001;322:1389-93. 11. Cho E., Manson JE, Stampfer MJ et al. A prospective study of obesity and risk of coronary heart disease among diabetic women. Diabetes Care 2002;25:1142-8.[Abstract/Free Full Text]
- Daousi C., Pinkney JH The impact of obesity on the prevalence of cardiovascular disease and diabetic complications in a hospital diabetic population. Diabet Med 2003;20(suppl 2):102 [Abstract].
- Henry RR, Wallace P., Olefsky JM Effects of weight loss on mechanisms of hyperglycaemia in obese non-insulin-dependent diabetes mellitus. Diabetes 1986;35:990-8.[Abstract]
- Williamson DF, Thompson TJ, Thun M., Flanders D., Pamuk E., Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 2000;23:1451-2.[Web of Science][Medline]
[Order article via Infotrieve]
- Pories WJ, Swanson M., MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg 1995;222:339-52.[Web of Science][Medline]
[Order article via Infotrieve]
- Pinkney JH, Sjostrom CD, Gale EAM. Should surgeons treat diabetes in very obese people? Lancet 2001;357:1357-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- MacDonald KG, Long S., Swanson M. et al. The gastric bypass operation reduces the progression and mortality of non-insulin dependent diabetes mellitus. J Gastrointest Surg 1997;1:213-20.[CrossRef][Medline]
[Order article via Infotrieve]
- Schauer PR, Burguera B., Ikramuddin S. et al. Effect of laparoscopic rouxen-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467-85.[Web of Science][Medline]
[Order article via Infotrieve]
- Dixon JB, O'Brien PE Health outcomes of severely obese type 2 diabetes subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002;25:358-63.[Abstract/Free Full Text]
- Gleysteen JG, Barboriak JJ, Sasse EA Sustained coronary risk factor reduction after gastric bypass for morbid obesity. Am J Clin Nutr 1990; 51:774-8.[Abstract/Free Full Text]
- Sjöström L. Surgical intervention as a strategy for the treatment of obesity. Endocrine 2000;13:213-30.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Letiexhe MR, Scheen AJ, Gerard PL, Desaive C., Lefebvre PJ Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism. J Clin Endocrinol Metab 1995;80:364-9.[Abstract]
- Greenway SE, Greenway FL, Klein S. Effects of obesity surgery on noninsulin-dependent diabetes mellitus. Arch Surg 2002;137:1109-17.[Abstract/Free Full Text]
- Cummings DE, Shannon MH Ghrelin and gastric bypass: Is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab 2003;88:2999-3002.[Free Full Text]
- Holdstock C., Engstrom BE, Ohrvall M., Lind L., Sundboum M., Karlsson FA Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 2003;88:3177-83.[Abstract/Free Full Text]
- Fruhbeck G., Diez Caballero A., Gil MJ Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med 2004;350:308-09.[Free Full Text]
- Stunkard AJ, Stinnett JL, Smoller JW Psychological and social aspects of the surgical treatment of obesity. Am J Psychiatry 1986;143:417-29.[Abstract/Free Full Text]
- National Institutes of Health Consensus Development conference. Am J Clin Nutr 1992;55:487S-619S.[Medline]
[Order article via Infotrieve]
- Livingston EH, Huerta S., Arthur D., Lee S., De Shields S., Heber D. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg 2003;236:576-82.[CrossRef][Web of Science]
- Sugarman HJ, Sugarman EL, DeMaria EJ et al. Bariatric surgery for severely obese adolescents. J Gastrointest Surg 2003;7:102-08.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
The British Journal of Diabetes & Vascular Disease, Vol. 4, No. 4,
232-237 (2004)
DOI: 10.1177/14746514040040040301

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. R Flatt, C. Day, and C. J Bailey
Review: Bariatric surgery: to treat diabesity
The British Journal of Diabetes & Vascular Disease,
May 1, 2009;
9(3):
103 - 107.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wilding
Obesity treatment: the key to managing the type 2 diabetes timebomb?
The British Journal of Diabetes & Vascular Disease,
July 1, 2004;
4(4):
217 - 219.
[PDF]
|
 |
|
|
|